Skip to main content

Halozyme Therapeutics, Inc 10-K for FY2023

Halozyme Therapeutics, Inc. (HALO)

10-K 2024-02-20 For: 2023-12-31
View Original
Added on April 11, 2026

About this 10-K

Halozyme Therapeutics, Inc filed this 10-K on February 20, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$829.25M
up 25.6% from $660.12M a year earlier
Net income
$281.59M
up 39.3% from net income of $202.13M a year earlier
Diluted EPS
$2.10
up 45.8% from $1.44 a year earlier